High-risk stays high-risk: Bruton tyrosine kinase inhibitors in B-cell malignancies

Haematologica. 2024 Mar 7. doi: 10.3324/haematol.2024.285029. Online ahead of print.ABSTRACTNot available.PMID:38450529 | DOI:10.3324/haematol.2024.285029

Source: Haematologica - March 7, 2024 Category: Hematology Authors: Othman Al-Sawaf Source Type: research